Monsanto Co. (MON) Receives “Outperform” Rating from BMO Capital Markets
Monsanto Co. (NYSE:MON)‘s stock had its “outperform” rating restated by equities research analysts at BMO Capital Markets in a research report issued on Saturday. They presently have a $128.00 target price on the stock. BMO Capital Markets’ price target points to a potential upside of 23.84% from the stock’s current price.
MON has been the subject of several other research reports. Piper Jaffray Cos. reissued an “overweight” rating and issued a $127.00 target price (up previously from $95.00) on shares of Monsanto in a research report on Monday, June 13th. Jefferies Group reissued a “buy” rating on shares of Monsanto in a research report on Tuesday, September 6th. Zacks Investment Research raised shares of Monsanto from a “strong sell” rating to a “hold” rating in a research report on Tuesday, September 6th. Monness Crespi & Hardt raised shares of Monsanto from a “neutral” rating to a “buy” rating and boosted their target price for the stock from $106.93 to $130.00 in a research report on Monday, August 8th. Finally, TheStreet downgraded shares of Monsanto from a “buy” rating to a “hold” rating in a research report on Monday, September 12th. Three investment analysts have rated the stock with a sell rating, eight have assigned a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the company. Monsanto currently has a consensus rating of “Buy” and a consensus target price of $114.67.
Shares of Monsanto (NYSE:MON) opened at 103.36 on Friday. Monsanto has a 12 month low of $83.73 and a 12 month high of $114.26. The firm has a market cap of $45.23 billion, a P/E ratio of 45.49 and a beta of 1.19. The company has a 50-day moving average of $104.86 and a 200-day moving average of $101.43.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/08/monsanto-co-mon-receives-outperform-rating-from-bmo-capital-markets.html
Monsanto (NYSE:MON) last issued its quarterly earnings data on Wednesday, October 5th. The company reported $0.07 EPS for the quarter, topping analysts’ consensus estimates of ($0.02) by $0.09. Monsanto had a net margin of 9.89% and a return on equity of 46.07%. The firm had revenue of $2.56 billion for the quarter, compared to analyst estimates of $2.38 billion. During the same quarter in the previous year, the business posted ($0.19) EPS. The firm’s revenue was up 8.8% compared to the same quarter last year. Equities analysts forecast that Monsanto will post $4.89 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Investors of record on Friday, October 7th will be given a $0.54 dividend. The ex-dividend date is Wednesday, October 5th. This represents a $2.16 annualized dividend and a dividend yield of 2.09%. Monsanto’s dividend payout ratio (DPR) is presently 71.05%.
In related news, COO Brett D. Begemann sold 27,980 shares of the company’s stock in a transaction that occurred on Thursday, July 14th. The shares were sold at an average price of $103.62, for a total value of $2,899,287.60. Following the completion of the sale, the chief operating officer now owns 102,480 shares in the company, valued at approximately $10,618,977.60. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Michael K. Stern sold 12,797 shares of the company’s stock in a transaction that occurred on Wednesday, July 13th. The shares were sold at an average price of $101.77, for a total transaction of $1,302,350.69. Following the completion of the sale, the chief executive officer now owns 21,583 shares of the company’s stock, valued at approximately $2,196,501.91. The disclosure for this sale can be found here. 0.88% of the stock is currently owned by corporate insiders.
Several large investors have recently modified their holdings of MON. Virginia Retirement System bought a new position in Monsanto during the first quarter valued at $626,000. JPMorgan Chase & Co. raised its position in Monsanto by 2.3% in the first quarter. JPMorgan Chase & Co. now owns 828,673 shares of the company’s stock valued at $72,708,000 after buying an additional 18,961 shares in the last quarter. NN Investment Partners Holdings N.V. bought a new position in Monsanto during the first quarter valued at $13,877,000. M&T Bank Corp raised its position in Monsanto by 16.4% in the first quarter. M&T Bank Corp now owns 77,720 shares of the company’s stock valued at $6,820,000 after buying an additional 10,927 shares in the last quarter. Finally, Ropes Wealth Advisors LLC raised its position in Monsanto by 5.5% in the first quarter. Ropes Wealth Advisors LLC now owns 2,798 shares of the company’s stock valued at $245,000 after buying an additional 147 shares in the last quarter. Institutional investors and hedge funds own 79.02% of the company’s stock.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related companies with MarketBeat.com's FREE daily email newsletter.